Biopharma Cold Chain Logistics Survey

Biopharma Cold Chain Logistics Survey

2019 Biopharma Cold Chain Logistics Survey

In 2019 Pelican Biothermal surveyed key opinion leaders in the biopharmaceutical industry to better understand emerging cold chain challenges. The 2019 Biopharma Cold Chain Logistics Survey report details the findings- revealing the concerns, trends and technologies that are top-of-mind for leaders in the biopharma production and distribution.
The survey uncovered three key trends driving top concerns around cold chain logistics. One trend is increasing quality demands as more sensitive products bring logistics complexity and greatly expanded risk. Awareness of temperature-controlled requirements is high, the survey results find that temperature excursions happen frequently – and they’re not always minor.

Another trend uncovered by the survey is the expanding distribution range as products move further and through more climatic zones than ever. More than half of survey respondents (51.8 percent) regularly ship products internationally – creating an increasingly complex web of local, regional and international connections that require a broad range of transport modes.

The final trend revealed through the survey is the need to optimize total cost of ownership (TCO) due to relentless competition and margin pressures. These pressures are leading organizations to take a closer look at defining TCO in their logistics and supply chain operations. A full 70 percent of survey respondents agree that TCO is important, while only 10 percent still merely look at basic packaging costs and transport rates.

To read the full 2019 Biophara Cold Chain Logistics Survey report, visit